XT
HRTX icon

XTX Topco’s Heron Therapeutics HRTX Stock Holding History

XTX Topco’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Sell
209,481
-30,716
-13% -$35.6K ﹤0.01% 2911
2025
Q4 		$312K Buy
240,197
+209,700
+688% +$259K 0.01% 2028
2025
Q3 		$38.4K Buy
+30,497
New +$48.4K ﹤0.01% 2216
2025
Q2 		– Sell
-84,405
Closed -$186K – 2704
2025
Q1 		$186K Sell
84,405
-213,080
-72% -$414K 0.01% 1720
2024
Q4 		$455K Sell
297,485
-83
-0% -$135 0.04% 847
2024
Q3 		$592K Buy
297,568
+243,363
+449% +$581K 0.04% 704
2024
Q2 		$190K Sell
54,205
-154,582
-74% -$475K 0.02% 1262
2024
Q1 		$578K Buy
208,787
+104,513
+100% +$263K 0.08% 403
2023
Q4 		$177K Buy
+104,274
New +$115K 0.04% 1002
2023
Q3 		– Sell
-407,825
Closed -$473K – 1756
2023
Q2 		$473K Buy
407,825
+171,851
+73% +$306K 0.08% 403
2023
Q1 		$356K Sell
235,974
-111,063
-32% -$278K 0.07% 515
2022
Q4 		$868K Buy
347,037
+265,914
+328% +$857K 0.18% 116
2022
Q3 		$342K Buy
81,123
+3,039
+4% +$11.9K 0.08% 423
2022
Q2 		$218K Buy
78,084
+57,648
+282% +$231K 0.09% 433
2022
Q1 		$117K Buy
+20,436
New +$150K 0.05% 491
2021
Q4 		– Sell
-26,811
Closed -$287K – 827
2021
Q3 		$287K Buy
+26,811
New +$326K 0.1% 352
2021
Q2 		– Sell
-11,872
Closed -$192K – 931
2021
Q1 		$192K Buy
+11,872
New +$212K 0.09% 509

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

XTX Topco's HRTX Position: Q1 2026 in Review

XTX Topco reduced its Heron Therapeutics (HRTX) stake by 13% in Q1 2026, selling an estimated $35.6K and leaving 209,481 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

XTX Topco first reported a position in HRTX in Q1 2021 and has held it in 17 quarters since. The position peaked at $868K in Q4 2022. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • XTX Topco held 209,481 shares of Heron Therapeutics worth $168K as of Q1 2026.
  • XTX Topco sold 30,716 Heron Therapeutics shares in Q1 2026, an estimated $35.6K.
  • Heron Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2911 holding.
  • XTX Topco first reported a position in Heron Therapeutics in Q1 2021 and has held it in 17 quarters since.
  • XTX Topco's Heron Therapeutics position peaked at $868K in Q4 2022.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.